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Herpes simplex virus 1 encodes a Fc receptor consisting of glycoproteins E (gE) and I (gI) and two protein kinases specified
by UL13 and US3, respectively. We report the following: (i) Antibody to UL13 formed immune complexes containing gE and gI
in addition to UL13 protein. Immune complexes formed by monoclonal antibody to gE, but not those formed by monoclonal
antibody to gI, also contained the UL13 protein. This association may reflect direct interaction between gE and UL13 inasmuch
as IgG in preimmune rabbit serum and an antiserum made against another viral protein which does not react with the UL13
protein directly also bound gE and UL13. (ii) In cells infected with the wild-type virus, gE formed two sharp bands and a diffuse,
slower migrating band. The slower sharp band was undetectable, and the diffuse slower migrating forms of gE were
diminished in lysates of cells infected with a mutant virus lacking the UL13 gene (DUL13). (iii) Both gE and gI were labeled with
32Pi in cells infected with wild-type or the DUL13 virus, but the labeling was significantly stronger in cells infected with the
wild-type virus than in those infected with the DUL13 virus. (iv) In an in vitro protein kinase assay, UL13 immunoprecipitated
from cells infected with wild-type virus labeled gE in the presence of [g-32P]ATP. This activity was absent in precipitates from
cells infected with DUL13 virus. The labeled gE comigrated with the slower, sharp band of gE. (v) gI present in the UL13
immune complex was also phosphorylated in the in vitro kinase assay. (vi) The cytoplasmic domain of gE contains recognition
sequences for phosphorylation by casein kinase II (CKII). Exogenous CKII phosphorylated gE in immune complexes from
lysates of cells infected with the DUL13 mutant or in immune complexes from lysates of cells infected with wild-type virus
that had been heated to inactivate all endogenous kinase activity including that of UL13. In both instances, CKII phosphor-
ylated gE in both the slow and fast migrating sharp bands. We conclude that UL13 physically associates with gE and mediates
the phosphorylation of gE and gI. UL13 may also be a determinant in posttranslational processing of gE. © 1998 Academic Press
INTRODUCTION
Herpes simplex virus 1 (HSV-1) encodes two protein
kinases specified by the UL13 and US3 genes (Coulter et
al., 1993; Cunningham et al., 1992; Daikoku et al., 1997;
Frame et al., 1987; Overton et al., 1992; Purves and
Roizman, 1992; Purves et al., 1986a,b, 1987). The kinase
specified by the UL13 gene is of particular interest since
the protein is packaged in the tegument, a structural
component of the virion located between the capsid and
the envelope (Coulter et al., 1993; Cunningham et al.,
1992; Overton et al., 1992) and indeed, a protein kinase
activity is associated with purified capsid–tegument
structures (Lemaster and Roizman, 1980). Tegument pro-
teins are generally released in the cytoplasm of newly
infected cells and therefore UL13 would be expected to
phosphorylate viral proteins and, possibly, cellular pro-
teins upon entry into cells. Genetically engineered vi-
ruses lacking the UL13 gene show reduced capacity to
replicate in nonhuman cells in culture (Purves et al.,
1993) and studies reported elsewhere indicate that UL13
phosphorylates itself and at least two viral proteins,
infected cell proteins 22 and 0 (ICP22 and ICP0) (Cun-
ningham et al., 1992, Ogle et al., 1997; Purves and Roiz-
man, 1992).
This report concerns the phosphorylation of HSV-1 Fc
receptor by the UL13 protein. Glycoprotein E (gE) acts as
a Fc receptor by itself and more strongly in association
with glycoprotein I (gI) (Dublin et al., 1990; Johnson et al.,
1988). gE specified by HSV-1 and also by other alpha-
herpesviruses such as HSV-2, Varicella zoster virus
(VZV), and pseudorabies virus are phosphorylated as
well as glycosylated (Edson, 1993; Edson et al., 1987;
Montalvo and Grose, 1986; Olson et al., 1997). The ho-
molog of HSV-1 gI encoded by VZV has also been re-
ported to be phosphorylated (Yao and Grose, 1994). The
identities of the protein kinases responsible for the phos-
phorylation of these two glycoproteins are largely un-
known, although the cytoplasmic domain of gE contains
several casein kinase II (CKII) recognition sequences
and CKII had been shown to phosphorylate VZV gE in
vitro (Litwin et al., 1992; Yao et al., 1993).
The studies described in this report stemmed from the
observation that antibody to UL13 formed complexes with
UL13, gE, and gI and that in an appropriate buffer con-
taining [g-32P]ATP, this complex phosphorylated the UL13
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protein, gE, and gI. We report that (i) in cells infected with
wild-type virus, gE forms two sharp bands and a diffuse
band on top of the two sharp bands. The slower migrat-
ing sharp band of gE is diminished or undetectable, and
the diffuse band is significantly reduced in lysate of cells
infected with the DUL13 mutant virus. The phosphoryla-
tion of gI is also reduced in lysate of cells infected with
the DUL13 mutant virus. (ii) UL13 specifically associates
with, and phosphorylates, gE in vitro. The labeled gE
comigrates with the slower, sharp band of gE. (iii) gI,
present in immune complexes containing UL13, is also
phosphorylated by UL13 in vitro. (iv) Purified CKII added
to immune complexes containing gE phosphorylates gE
but the pattern of phosphorylation is different from that
phosphorylated by UL13.
RESULTS
Accumulation of UL13 protein is reduced in cells
infected with DgE virus
The specificity of the rabbit polyclonal antiserum to
GST–UL13 fusion protein prepared as described under
Materials and Methods was tested on electrophoretically
separated proteins from 35S-labeled cells that were
mock infected or infected with wild-type virus HSV-1(F),
recombinant viruses R7356 lacking the UL13 gene
(DUL13), R7032 lacking the gene specifying glycoprotein
gE (DUS8), or R7048 lacking both the gE and gI genes
(DUS7/DUS8). As shown in Fig. 1, the antiserum reacted
with a Mr 57,000 protein that was present in lysates of
wild-type virus-infected cells (Figs. 1A and 1B, lane 2) but
absent in those of mock-infected cells (Fig. 1B, lane 1) or
in lysates of cells infected with the DUL13 mutant (Figs.
1A and 1B, lane 3). The apparent molecular weight of the
protein corresponds to that predicted for UL13 (McGeoch
et al., 1988). The antibody was further tested in different
types of infected cells (Fig. 2). Again, the antiserum
detected a protein with a Mr of 57,000 in electrophoreti-
cally separated proteins from lysate of wild-type [HSV-
1(F)]-infected rabbit skin cells or Vero cells (Fig. 2B, lanes
2 and 6). The preimmune serum from the rabbit did not
react specifically with any protein in the infected cells
(Fig. 2A, lanes 2 and 3). The expression of UL13 was also
examined in the R7032 (DUS8)-infected cells. We ob-
served that the accumulation of UL13 protein was de-
creased compared with that of the wild-type virus-in-
fected cells (compare Fig. 2B, lanes 4 and 8 with lanes 2
and 6). In fact, the accumulation of UL13 protein was
lower in cells infected with mutants lacking gE or both gE
and gI (Figs. 1A and 1B, lanes 4 and 5) than in cells
infected with wild-type virus (Figs. 1A and 1B, lane 2). In
Fig. 2, ICP27 served as an infectivity/loading control. As
shown in Fig. 2B, the amounts of ICP27 were similar in all
lysates of infected cells.
It has been observed that the expression of some viral
genes, especially late genes, was delayed in cells in-
fected with the DgE virus (unpublished studies from this
laboratory). Since the accumulation of some late proteins
in cells infected with the UL13 deletion virus are also
decreased due to the lack of the modification of ICP22 in
FIG. 1. (A) Autoradiographic image of 35S-labeled cell lysates infected with parent and mutant viruses. Replicate cultures of Vero cells were either
mock infected or infected with HSV-1(F), R7356 (DUL13), R7032 (DgE), or R7048 (DgE, DgI) virus. At 12.5 h after infection, the cells were labeled with
a mixture of [35S]methionine and [35S]cysteine for 6 h. Cells were then solubilized, electrophoretically separated in a 10% denaturing polyacrylamide
gel, and electrically transferred to a nitrocellulose sheet. (B) The nitrocellulose sheet was reacted with UL13 antiserum and subsequently with ECL
immunoblotting reagents to detect the position of UL13.
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the absence of UL13 protein (Purves et al., 1993), we
examined the modification of ICP22 in cells infected with
the gE deletion virus. Indeed, in rabbit skin cells infected
with DUS8 virus, the processing of ICP22 proteins is
reduced relative to that of wild-type infected cells (com-
pare Fig. 2B, lanes 2 and 4). However in Vero cells the
processing of ICP22 in cells infected with the DUS8
protein cannot be differentiated from that observed in
wild-type virus-infected cells (compare Fig. 2B, lanes 6
and 8) and yet the synthesis of late proteins in these cells
was delayed. We conclude therefore that the evidence
available at this time does not relate the reduction in late
protein synthesis in cells infected with the DUS8 virus to
altered processing of ICP22.
UL13 forms a complex with the Fc receptor
The UL13 antiserum was tested for its ability to immu-
noprecipitate UL13 from infected cell lysate. In these
series of experiments, immune complexes obtained from
the reaction of antisera with lysates of 35S-labeled in-
fected cells were subjected to electrophoresis simulta-
neously and in the same apparatus as those shown in
Fig. 1. The proteins separated by electrophoresis was
electrically transferred to a nitrocellulose sheet. The key
results of this experiment were as follows:
(i) The immune complexes from wild-type virus-in-
fected cell lysate contained a protein band with an ap-
parent Mr of 57,000 (Fig. 3A, lane 6). This protein band
migrated to the same position as the UL13 protein in the
polyacrylamide gel shown in Figs. 1A and 1B, lane 2), but
was absent from immune complexes obtained with ly-
sate of cells infected with DUL13 virus (Fig. 3A, lane 5). In
an attempt to verify the identify of the Mr 57,000 protein,
the nitrocellulose sheet was reacted with the UL13 anti-
serum, but the protein migrated so close to the heavy
chain of IgG brought down by immunoprecipitation that it
was impossible to differentiate the protein from the IgG
in this particular polyacrylamide gel (data not shown). As
reported elsewhere, the anti-UL13 serum does react with
this protein, indicating that this protein is UL13 (Ogle et
al., 1997).
(ii) The anti-UL13 serum also precipitated several pro-
tein species with apparent Mrs ranging from 60,000 to
85,000. Additional studies revealed that these bands
contained the Fc receptors encoded by HSV-1 gE and gI,
inasmuch as they were not detected in immune com-
plexes obtained with the anti-UL13 antibody from lysate
of cells infected with DUS8 (DgE) or DUS8/DUS7 (DgE/
DgI) mutants (Fig. 3A, lanes 3 and 4). gE has been
reported to form several diffuse bands ranging in appar-
ent Mrs from 80,000 to 85,000 (Para et al., 1982), whereas
the apparent Mr of gI has been reported to range from
60,000 to 70,000 (Johnson et al., 1988). Separation of
proteins in immune complexes from lysate of wild-type-
infected cells on a lower percentage polyacrylamide gel
and a shorter exposure of the autoradiograph yielded
two major forms of gE (Fig. 3B, lane 2), whereas only the
band with the faster mobility was apparent in precipi-
tates from lysate of cells infected with the DUL13 mutant
(Fig. 3B, lane 3). The monoclonal antibody to gE reacts
specifically with a double and single band in the immu-
noblot (Fig. 3C) that matches the bands seen in Fig. 3B,
unambiguously identifying these bands as gE (Fig. 3C,
lanes 2 and 3). We should stress that in these series of
experiments, as shown in Fig. 3B, the data clearly relate
the presence of the slow migrating band E with the
presence of the UL13 kinase.
(iii) Binding of HSV-1 Fc receptor to an antigen–anti-
body complex would not per se evoke a great surprise.
Additional experiments, however, led to the observation
FIG. 2. Electrophoretic profiles of UL13, ICP22, and ICP27 made in rabbit skin cells (RSC) or Vero cells infected with parent and mutant viruses.
Replicate cell cultures were either mock infected or infected with HSV-1(F), R7356 (DUL13), or R7032 (DgE) virus. The infected cells were harvested
at 24 h after infection, solubilized, electrophoretically separated in a denaturing 8.5% polyacrylamide gel, electrically transferred to a nitrocellulose
sheet, and reacted with preimmune serum (A) or UL13 antiserum, R77 antiserum (ICP22), and monoclonal antibody H1117 (ICP27) (B).
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that the Fc receptor may be binding to the UL13 protein
and not merely to IgG. Specifically, as shown in Fig. 3A,
immune complexes obtained from wild-type virus-in-
fected lysate with the UL13 preimmune serum (lane 9) or
with an anti-UL32 polyclonal antibody (lane 2) contained
a protein band with an apparent Mr identical to that of the
UL13 protein. Since neither the preimmune serum (Fig.
2A) nor the UL32 antiserum reacted with UL13 in previous
assays (Chang et al., 1996), one explanation for this
observation is that UL13 was bound to and precipitated
with the Fc receptor complex.
Phosphorylation of gE and gI in infected cells is
dependent on UL13
In the next series of experiments we examined the
proteins present in immune complexes captured by the
anti-UL13 polyclonal antibody from lysate of
32P-labeled
mock-infected and infected cells. Several phosphopro-
teins were captured in immune complexes by the UL13
antiserum from cell lysate infected with wild-type virus or
DUL13 virus (Fig. 4A, lanes 7 and 8), but not from lysate
of cells infected with DgE virus (lane 9) or the DgE/DgI
virus (lane 10). Again, the profile of the phosphoproteins
resembled those of gE and gI (Fig. 4A, lanes 2, 3, 7, and
8). As expected, both preimmune and immune sera cap-
tured gE and gI. Since HSV-1 gE and VZV gI had been
reported to be phosphoproteins (Edson et al., 1987; Yao
and Grose, 1994), we verified the identities of these
proteins by immunobloting with monoclonal antibodies
specific to gE and gI. The gE antibody reacted with a
doublet of sharp bands as well as a very broad band of
diffuse protein above the doublet from cells infected with
wild-type virus (Fig. 4B, lanes 2 and 7), but with a single
sharp band and a much less diffuse, slow migrating
band in cells infected with R7356 (DUL13) virus (Fig. 4B,
lanes 3 and 8). We should note that the slow and fast
migrating band of gE were less well resolved in this gel
than in the gel shown in Figs. 3B or 5C. The gI antibody
reacted with a major broad band and a slower migrating
band from lysate of cells infected with wild-type virus or
the UL13 deletion virus (Fig. 4C, lanes 2, 3, 7, and 8).
The gE and gI bands formed by immune complexes
from cells infected with the R7356 (DUL13) virus (Fig. 4A,
lanes 3 and 8) exhibited substantially less phosphoryla-
tion than those of cells infected with the wild-type virus
(Fig. 4A, lanes 2 and 7). The amounts of radioactivity
quantified with the aid of a Betagen Betascope showed
that the labeling of the individual bands of gE and gI in
lanes 3 and 8 of Fig. 4A (DUL13) constitute approximately
40% of the corresponding labeling of the glycoproteins
from wild-type virus-infected cells shown in Fig. 4A
(lanes 2 and 7). The immunoblot showed that the amount
of the faster migrating sharp band of gE in the lysate of
DUL13 mutant virus (Fig. 4B, lanes 3 and 8) was compa-
rable to the corresponding band in the lysates of cells
infected with wild-type virus (Fig. 4B, lanes 2 and 7).
As noted above, the gE from lysate of wild-type virus
infected cells formed a diffuse, heterogeneous mass of
proteins migrating more slowly than the doublet of sharp
bands (Figs. 4A and 4B, lanes 2 and 7). These hetero-
genous forms of gE were less abundant and migrated
faster in cells infected with the DUL13 mutant (Figs. 4A,
FIG. 3. (A) Autoradiographic image of 35S-labeled infected cell lysate
immunoprecipitated by UL13, UL32, or preimmune antiserum. Replicate
cultures of Vero cells were either mock infected or infected with
HSV-1(F), R7356 (DUL13), R7032 (DgE), or R7048 (DgE, DgI) virus. At
12.5 h after infection, the cells were labeled by a mixture of [35S]me-
thionine and [35S]cysteine for 6 h. Cells were then solubilized and
immunoprecipitated with UL32 polyclonal antiserum (lanes 1 and 2),
UL13 polyclonal antiserum (lanes 3–7), and preimmune serum (lanes
8–10). The precipitated proteins were eluted from protein A–Sepharose,
electrophoretically separated in a 10% denaturing polyacrylamide gel,
and electrically transferred to a nitrocellulose sheet. UL13 is identified
by a filled circle in A. (B) Autoradiographic image of 35S-labeled in-
fected cell lysate immunoprecipitated by UL13 antiserum. Replicate
cultures of Vero cells were either mock infected or infected with
HSV-1(F), R7356 (DUL13), or R7032 (DgE) virus. The cells were infected
and processed in the same way as described in A except that the
samples were electrophoretically separated in a 8.5% denaturing poly-
acrylamide gel and electrically transferred to a nitrocellulose sheet. (C)
Photograph of the nitrocellulose sheet shown in B after immunoblotting
with the gE-specific monoclonal antibody. The slower migrating sharp
band of gE is identified by a filled circle in lane 2 of B and C.
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and 4B, lanes 3 and 8). This decrease in the amounts of
the highly modified gE was also observed in 35S-labeled
cells (Fig. 3A, lane 5).
It had been reported that UL13 is a phosphoprotein
(Overton et al., 1992). UL13 in cells incubated with me-
dium containing 32Pi for 4 h was poorly labeled (Fig. 4A,
lane 7). To improve the labeling of UL13, the infected cells
were labeled from 5 to 22 h after infection. This longer
period of incubation with 32Pi greatly improved the label-
ing of UL13. We identified a labeled phosphoprotein of Mr
57,000, which was immunoprecipitated from lysate of
cells infected with wild-type virus (Fig. 4A, lane 13), but
not from that infected by the DUL13 virus (Fig. 4A, lane
14). Again, a small amount of UL13 was captured in
complexes formed by IgG from preimmune serum of
UL13 (Fig. 4A, lane 11).
We conclude (i) that gE and gI found in immunopre-
cipitates are phosphorylated, (ii) that the extent of phos-
phorylation is higher in wild-type-infected cells than in
cells infected with the DUL13 mutant, and last (iii) that the
slower migrating sharp band of gE is associated with the
presence of a functional UL13 gene. These results sug-
FIG. 4. (A) Autoradiographic image of [32P]orthophoshate-labeled infected cell lysate immunoprecipitated by UL13 or preimmune rabbit serum. (i)
Lanes 1–10: replicate cultures of Vero cells were either mock infected or infected with HSV-1(F), R7356 (DUL13), R7032 (DgE), or R7048 (DgE, DgI) virus;
at 14 h after infection, the cells were labeled with 32Pi for 4 h. (ii) Lanes 11–14: replicate cultures of Vero cells were infected with HSV-1(F) or R7356
(DUL13) virus; at 6 h after infection, the cells were labeled with
32Pi for 16 h. Cells were then solubilized and reacted with the preimmune serum (lanes
1–5, 11, 12) or the anti-UL13 polyclonal serum (lanes 6–10, 13, 14). The complexes containing IgG were collected with protein A–Sepharose, eluted,
electrophoretically separated in a denaturing 8.5% polyacrylamide gel, electrically transferred to a nitrocellulose sheet, and reacted with gE-specific
monoclonal antibody (II481B2) (B) or monoclonal antibody specific for gI (Fd69) (C). In A, UL13 is identified by a filled circle (lanes 11 and 13) and in
B, the slower migrating sharp band of gE is identified by filled circles in lanes 2 and 7.
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gest that UL13 is mediating the posttranslational modifi-
cation of gE and both the phosphorylation of gE and gI in
infected cells.
gE is phosphorylated by UL13 in vitro
The purpose of these series of experiments was to
test the protein kinase activity of UL13 protein present in
immune complexes. Figures 5A and 5B show the im-
mune complexes obtained with anti- UL13 antibody, in-
cubated in a protein kinase buffer containing [g-32P]ATP,
electrophoretically separated on a denaturing gel, trans-
ferred electrically to a nitrocellulose membrane, and sub-
jected to autoradiography for either 2 h (Fig. 5A) or 24 h
(Fig. 5B), respectively. Figure 5C shows a photograph of
the nitrocellulose membrane reacted with the monoclo-
nal antibody to gE, and Fig. 5D shows the autoradio-
graphic image of the membrane reacted with the gI
monoclonal antibody and ECL detection reagents. The
results were as follows:
(i) The immune complexes containing UL13 phosphor-
ylated a protein with the electrophoretic mobility of UL13
protein and also mediated the phosphorylation of a
slower migrating protein that coprecipitated with the
UL13 immune complex (Fig. 5A, lane 1). The phosphory-
lation of UL13 was a result of autophosphorylation since
phosphorylated proteins were not detected in assays of
immune precipitates obtained from lysate of cells in-
fected with R7356 (DUL13) virus (Fig. 5A, lane 4), even
after prolonged autoradiography (Fig. 5B, lane 4). Fur-
thermore, UL13 was the only protein labeled in immune
complexes from lysate of cells infected with R7032 (DgE)
virus (Fig. 5B, lane 3). As noted in Figs. 1 and 2, cells
infected with DgE virus accumulated less UL13 protein
than cells infected with wild-type virus. Consistent with
this finding, phosphorylated UL13 protein in immune
complexes obtained with UL13 antibody from lysate of
cells infected with DgE virus was observed only on
prolonged autoradiography (Fig. 5B, lane 3). This de-
crease in the amount of UL13 may also reflect the amount
of UL13 immunoprecipitated in the absence of the Fc
receptor.
(ii) Two lines of evidence indicate that the slower
migrating, phosphorylated protein was a component of
the Fc receptor. First, Fig. 5C shows that the slow mi-
grating 32P-labeled band in Fig. 5A, lanes 1 and 2, cor-
responded to the slower migrating band of a doublet
which reacted with the monoclonal antibody to gE. Sec-
ond, we depleted the Fc receptor by reacting a mixture of
infected cell lysate and preimmune serum with protein A
before immunoprecipitation with UL13-specific anti-
serum. This procedure resulted in the removal of a sub-
stantial amount of the more slowly migrating phospho-
protein and a slight decrease in the recovery of the
autophosphorylated UL13, indicating that the slower mi-
grating form was a component of the Fc receptor (Figs.
5A and 5C, lane 2).
The specificity of the phosphorylation of gE was ap-
parent from the absence of labeled gE in immune com-
plexes from lysate of R7356 (DUL13)-infected cells (Figs.
5A and 5B, lane 4) or those of R7032 (DgE)-infected cells
(Figs. 5A and 5B, lane 3). We conclude from these series
of experiments that gE was specifically phosphorylated
by the precipitated UL13.
(iii) In Fig. 4, gI was shown to be a phosphoprotein
that coprecipitated with the UL13 immune complex. It
FIG. 5. (A and B) Autoradiographic images of electrophoretically separated proteins labeled with [32P]ATP in in vitro protein kinase assays. Replicate
cultures of Vero cells were infected with HSV-1(F), R7356 (DUL13), or R7032 (DgE) virus. At 24 h after infection, the infected cells were solubilized. The
cell lysates shown in lane 2 were reacted with preimmune serum for 2 h and then with protein A–Sepharose for 1.5 h to deplete the HSV-1 Fc receptor.
All the other cell lysates were incubated with protein A for 1.5 h. At the end of the reaction, the precleared cell lysates were mixed with UL13 antiserum
and the immune complexes harvested with protein A beads. The complexes were rinsed extensively, reacted in the kinase buffer in the presence of
[g-32P]ATP, rinsed again, eluted from protein A–Sepharose, electrophoretically separated in a denaturing polyacrylamide gel, electrically transferred
to a nitrocellulose sheet, and exposed to X-ray film for 2 h (A) or 24 h. (B). (C) The nitrocellulose was reacted with gE-specific monoclonal antibody
(II481B2). (D) The nitrocellulose was reacted with gI-specific monoclonal antibody (Fd69).
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was of interest to determine whether UL13 could mediate
the phosphorylation of gI in the protein kinase assay. The
nitrocellulose membrane shown in Fig. 5A was reacted
with the monoclonal antibody to gI. The results, shown in
Fig. 5D, indicate that gI migrated to locations intermedi-
ate between those of UL13 protein and gE, and, as could
be expected, the amounts of gI were decreased after
depletion of Fc receptor from cell lysate (Fig. 5D, lane 2).
The protein bands formed by gI did not correspond to
any strong 32P-labeled band in Fig. 5A.
gI is phosphorylated by UL13 in vitro
Daikoku et al. reported that NaCl inhibited the activity
of the UL13 protein kinase. In an attempt to determine if
NaCl inhibited the phosphorylation of gI shown in lane 1
of Fig. 5D, immune complexes of UL13 was incubated in
a protein kinase buffer containing NaCl concentration
reduced from 200 mM to 100 mM NaCl (Fig. 6A, right)
and 0 mM NaCl (Fig. 6A, left). The reactions were elec-
trophoretically separated on a denaturing gel, trans-
ferred electrically to a nitrocellulose membrane, and sub-
jected to autoradiography for 16 h (Fig. 6A). Figure 6B
shows a photograph of the nitrocellulose membrane
reacted with the monoclonal antibody to gI. The results
were as follows:
The immune complexes containing UL13 phosphory-
lated UL13 and also mediated the phosphorylation of two
slower migrating proteins that coprecipitated with the
UL13 immune complex (Fig. 6A, lanes 1 and 3). The upper
band was identified as gE (data not shown). In Fig. 6A the
middle 32P-labeled band corresponded to a band which
reacted with the monoclonal antibody to gI (Fig. 6B). We
conclude from this experiment that gI was phosphory-
lated by the precipitated UL13 in vitro.
UL13 is coprecipitated with gE
Evidence from Figs. 3 and 4 suggested that UL13 was
captured in immune complexes with the Fc receptor. To
determine which component of the Fc receptor UL13
associates with, the immunoprecipitate of UL13 was
compared with those of monoclonal antibodies of gE or
gI in a protein kinase assay. The UL13 antiserum immu-
noprecipitated both UL13 and a small amount of gE (Fig.
7A, lane 1), while the gE monoclonal antibody immuno-
precipitated the gE protein and a small amount of a
protein with an electrophoretic mobility characteristic of
UL13 protein (Fig. 7A, lane 2). The protein kinase assay
done on the gE immunoprecipitate from R7356 (DUL13)
virus-infected cells failed to label gE due to the absence
of UL13 in the immunoprecipitate (Fig. 7A, lane 3). No
phosphorylated proteins were detected in the kinase
assays of immune complexes obtained with the gI mono-
FIG. 7. (A) Autoradiographic image of proteins contained in immune
complexes and labeled in an in vitro protein kinase reaction. Replicate
cultures of Vero cells were infected with HSV-1(F), R7356 (DUL13), or
R7032 (DgE). The lysates of cells harvested at 24 h after infection were
precleared with protein A and then reacted with anti-UL13 polyclonal
antiserum (lane 1), gE monoclonal antibody (H600) (lanes 2 and 3), or
gI monoclonal antibody (Fd69) (lanes 4–6). Immune complexes were
tested in the protein kinase assay as described in Fig. 5 and also under
Materials and Methods, rinsed again, and processed for autoradiog-
raphy as described in Fig. 5. (B) Photograph of the nitrocellulose
membrane containing lanes 4–6 in A after reaction with the anti-gI
monoclonal antibody (Fd69).
FIG. 6. (A) Autoradiographic images of proteins phosphorylated in an
in vitro protein kinase assay. Vero cells were infected with HSV-1(F),
R7356 (DUL13), or R7358 (DUL13 repair). At 24 h after infection the cells
were solubilized. The cell lysates were precleared with protein
A–Sepharose and then immunoprecipitated with the UL13 polyclonal
antibody. The kinase assay was carried out as described under Mate-
rials and Methods. The kinase reactions were electrophoretically sep-
arated in a denaturing polyacrylamide gel, electrically transferred to a
nitrocellulose sheet, and exposed to X-ray film for 24 h. (B) Photograph
of the nitrocellulose sheet after reaction with gI-specific monoclonal
antibody (Fd69).
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clonal antibody and lysates of wild-type, R7356 (DUL13),
or R7032 (DgE) virus-infected cells (lanes 4–6). To con-
firm that gI was immunoprecipitated by the gI monoclo-
nal antibody, the nitrocellulose membrane correspond-
ing to lanes 4–6 in Fig. 7A was reacted with gI
monoclonal antibody. As shown in Fig. 7B, lanes 1–3, gI
was present in the immunoprecipitates, indicating that gI
did not associate with the UL13 protein under these
experimental conditions.
Casein kinase II can phosphorylate gE in vitro
The homolog of HSV-1 gE in VZV was reported to be
phosphorylated by CKII in vitro (Litwin et al., 1992). Both
the HSV-1 and VZV gE have CKII recognition sequences
in the cytoplasmic domains of the proteins (Litwin et al.,
1992). In an attempt to determine if HSV-1 gE can be
phosphorylated by CKII in vitro, gE immunoprecipitated
from R7356 (DUL13)-infected cells was reacted with CKII
in a protein kinase assay in vitro in the presence of none
or 0.5 or 5 mg/ml of heparin in the kinase buffer (Fig. 8,
lanes 9–11). gE was phosphorylated by CKII in vitro (lane
9) and this phosphorylation was inhibited by heparin
(lanes 10–11). In another part of the experiment, CKII was
incubated with UL13 immune complexes containing gE
immunoprecipitated from cells infected with the wild-
type virus. To inactivate all endogenous kinase activity,
the immune complexes were heat-inactivated prior to the
addition of CKII. This procedure inactivated all endoge-
nous kinase activity (Fig. 8, lane 4), but did not affect the
capacity of gE to be phosphorylated by CKII (Fig. 8, lane
5). As expected, the CKII activity was inhibited by heparin
(lanes 7 and 8). Finally, heparin did not affect the activity
of UL13 kinase in assays with precipitates from wild-type-
infected cells (Fig. 8, lanes 1–3). Interestingly, gE phos-
phorylated by CKII formed two bands (Fig. 8, lanes 5 and
9) whereas, as shown earlier, gE phosphorylated by UL13
migrated as a slower migrating band.
Repair of the DUL13 gene restores protein kinase
activity and posttranslational processing of the Fc
receptor
In an in vitro protein kinase assay with lysate of cells
infected by the DUL13 virus, the phosphorylation of the Fc
receptor was completely abolished (Fig. 6A, lanes 2).
Also, in immunoprecipitates from DUL13 virus-infected
cell lysates labeled in vivo with [32P]orthophosphate us-
ing the anti-UL13 antiserum, the posttranslational pro-
cessing and overall phosphate labeling of gE and gI
were diminished (Fig. 9B, lane 2). To verify that the
FIG. 9. Photograph and autoradiogram of an electrophoretically sep-
arated immune precipitate obtained from 32P-labeled infected cell ly-
sates with anti-UL13 antibody. (A) Photograph of the electrophoretically
separated preciptate after reaction with anti-gI-specific monoclonal
antibody (Fd69). (B) Autoradiographic image of 32P of the electro-
phoretically separated precipiated obtained with the anti-UL13 antibody
from lysates of Vero cells infected with HSV-1(F), R7356 (DUL13), or
R7358 (DUL13 repair). The cells were labeled with [
32P]orthorphosphate
at 14 h after infection for 4 h and then harvested, solubilized, immuno-
precipitated with the anti-UL13 rabbit polyclonal antiserum, and eluted
from protein A–Sepharose. All samples were electrophoretically sepa-
rated in an 8% denaturing polyacrylamide gel and transferred to a
nitrocellulose sheet for autoradiography and reaction with the anti-gI
antibody.
FIG. 8. Autoradiographic images of gE phosphorylated by purified
CKII. Replicate cultures of Vero cells were infected with HSV-1(F) or
R7356 (DUL13). At 24 h after infection, the infected cells were solubi-
lized. All the cell lysates were precleared with protein A and then
immunoprecipitated with anti-UL13 polyclonal antibody (lanes 1–7) or
gE monoclonal antibody (H600) (lanes 8–11). Immune complexes in
lanes 4–7 were heated-inactivated at 65°C for 10 min. All immune
complexes were then reacted with [g-32P]ATP and UL13 protein kinase
buffer (lanes 1–3), or CKII protein kinase buffer (lanes 4 and 8), or a
mixture of CKII protein kinase buffer containing exogenous, purified
CKII (lanes 5–7 and 9–11). Heparin in final concentrations of 0.5 mg/ml
(lanes 3, 7, and 11) or 5 mg/ml (lanes 2, 6, and 10) was added to the
protein kinase buffer mixture to inhibit CKII kinase activity. On termi-
nation of the assay, the immune complexes were rinsed again and
processed for autoradiography as described in the legend to Fig. 5 and
under Materials and Methods.
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protein kinase activity and differential phosphorylation
observed in this study was exclusively due to the UL13
gene, R7358, the virus in which the UL13 gene had been
restored, was tested. Figure 6A shows the immune com-
plexes obtained with the anti-UL13 antibody, incubated in
protein kinase buffer with different NaCl concentrations,
electrophoretically separated on a denaturing gel, trans-
ferred to a nitrocellulose sheet, and subjected to auto-
radiograph for 16 h. In cells infected with the UL13 repair
virus (R7358), the specific kinase activity is restored,
resulting in phosphorylation of UL13, gE, and gI (Fig. 6A,
compare lanes 2 and 3).
The phosphorylation of gE and gI in cells infected with
the UL13 repair virus was also examined (Fig. 9B). Im-
mune complexes obtained from Vero cells infected with
HSV-1(F), R7356(DUL13), and R7358 (DUL13 repair) and
labeled with [32P]orthophosphate from 14 to 18 h after
infection were electrophoretically separated on a dena-
turing gel, transferred to a nitrocellulose sheet, and sub-
jected to autoradiography for 2 h. (Fig. 9A shows the
immunoblot of the nitrocellulose with gI monoclonal an-
tibody to detect the amount of gI in each sample. The
phosphorylation of gE and gI in cells infected with the
repair virus (R7358) was restored to a level comparable
to that of the wild-type virus (Fig. 9B, compare lanes 1
and 3). These results suggest that UL13 is responsible for
the phosphorylation of gE and gI in infected cells and the
loss of this activity is not due to some unknown second-
ary mutation in the DUL13 virus.
DISCUSSION
The salient features of the results presented in this
report are as follows:
(i) We expected that complexes containing IgG, either
bound to an antigen or free, would bind the HSV-1 Fc
receptor glycoproteins, gE and gI. We did not expect,
however, that complexes containing IgG directed to an
irrelevant antigen would contain the UL13 protein. Since
UL13 is captured by gE monoclonal antibody, but not by
gI monoclonal antibody, these results suggest that the
interaction is primarily between gE and UL13 protein.
gE is a phosphoprotein located in the virion membrane
and, by necessity, in the nuclear membrane for the pre-
envelopment of the capsid. The UL13 protein is a tegu-
ment protein and partially responsible for the kinase
activity demonstrated in purified capsid–tegument struc-
tures (Lemaster and Roizman, 1980, and unpublished
data this laboratory). In principle, there are at least two
explanations for the surprising affinity of the UL13 protein
for gE. The first and most straightforward explanation is
that gE is a substrate for UL13. The second and more
complex explanation is that gE, as an envelope protein,
serves as an anchor for the packaging of UL13. In this
report, we show that gE is in fact a substrate for UL13, as
discussed more fully below. We have not excluded a role
for gE in the packaging of UL13 protein since this would
require an analysis of virions made from cells infected
with the DgE virus.
(ii) gE from wild-type virus-infected cells forms two
sharp bands and a diffuse, heterogeneous and slower
migrating mass in denaturing polyacrylamide gels. In
cells infected with DUL13 virus, the slower migrating
sharp band and the diffuse, heterogenous mass are
grossly diminished. In in vitro protein kinase reactions
containing UL13 and gE, the
32P label appears only in the
slower migrating sharp band. These observations sug-
gest that the UL13 kinase is responsible for both the
phosphorylation and, possibly, posttranslational pro-
cessing of gE, but it remains to be seen whether the
change in electrophoretic mobility is a direct effect of the
phosphorylation of gE by UL13.
(iii) The results of the experiments shown in Fig. 4
unambiguously show that UL13 does not account for all
of the phosphorylation of gE and gI. CKII is a serious
candidate for a kinase responsible for the phosphoryla-
tion of gE. Specifically, gE has several CKII recognition
sites in the endodomain accessible to the cytoplasm and
nucleoplasm depending on the location of the mem-
brane containing gE (Litwin et al., 1992). In this study we
showed that purified CKII added to immune complexes
phosphorylated gE in the absence of any endogenous
kinase activity. We also showed that the CKII activity is
sensitive to heparin and that, conversely, the protein
kinase activity in the in vitro reaction attributed to UL13 is
insensitive to heparin. It has recently been reported that
the UL13 kinase purified from HSV-2-infected cells is also
insensitive to heparin inhibition (Daikoku et al., 1997).
The experimental results shown in Fig. 8 indicate, how-
ever, that CKII can account for some but not all of the
phosphorylation of gE observed in the absence of UL13.
This conclusion is based on the observation that in the
absence of UL13, gE forms predominantly the faster mi-
grating sharp band and a smaller amount of slower
migrating diffuse, heterogeneous band (Fig. 3B, lane 3,
and Figs. 4A and 4B, lanes 3 and 8). The gE phosphor-
ylated in vitro by CKII forms two relatively sharp bands
(Fig. 8, lanes 5 and 9). This suggests that if CKII is
involved in phosphorylation of gE, it contributes primarily
to the faster migrating band and to trace amounts of the
slower migrating sharp band formed by gE contained in
lysate of cells infected with wild-type virus (compare Fig.
4B lanes 3 and 8 with Fig. 8 lanes 5, 9, and 11).
(iv) In this study, we presented both in vivo (infected
cells) and in vitro evidences that UL13 can mediate the
phosphorylation of gE and gI. We have not been able to
demonstrate, however, an interaction between gI and
UL13. Immune complexes containing monoclonal anti-
body to gI did not capture UL13 in detectable amounts.
(v) Last, the issue arises as to why gE and gI are
phosphorylated by seemingly a myriad of protein ki-
nases. By analogy with other viral proteins, we may
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postulate that gE and possibly both gE and gI perform
several functions and that the various protein kinases
direct the functions of the glycoproteins by modifying
them at different sites. In point of fact, gE and gI have
been reported to play a role in blocking some host
responses to infection (Dublin et al., 1991), and to play a
role in the spread of virus from cell to cell (Dingwell et al.,
1994, 1995); in psuedorabies virus the endodomain of the
gE homologue has been shown to contribute to neuro-
virulence (Tirabassi et al., 1997), and more recently evi-
dence has accumulated that the expression of late
genes is delayed in cells infected with DgE viruses
(unpublished data from this laboratory). Identification of
the various kinases and the sites they modify may help




Vero cells were obtained from the American Type
Culture Collection. The rabbit skin cells were originally
from John McClaren. HSV-1(F) is the prototype strain
used in this laboratory (Ejercito et al., 1968). The con-
structions of HSV-1 recombinant viruses R7032, R7048,
R7356, and R7358 were reported elsewhere (Longnecker
et al., 1987; Meignier et al., 1988; Purves and Roizman,
1992; Purves et al., 1993). Table 1 lists the genotypes of
all the viruses used in this study.
Production of GST fusion protein to UL13 and
production of UL13 rabbit antiserum
The entire coding domain of the UL13 gene was am-
plified by PCR and fused to the glutathione S-transferase
(GST) gene in pGEX-4T-1 plasmid (Pharmacia). PCR am-
plification was done with the PFU DNA Polymerase
(Stratagene). The resultant plasmid was designated
pRB5151. Escherichia coli BL21 cells transformed with
pBR5151 were grown to an optical density of at least 0.5
at A600, induced with 0.1 mM IPTG (isopropylthiogalacto-
pyranoside) for 4 h and then harvested and lysed by
sonication in phosphate-buffered saline (PBS-A: 0.14 M
NaCl, 3 mM KCl, 10 mM Na2HPO4, 1.5 mM KH2PO4). After
addition of Triton X-100 to a final concentration of 1%, the
GST–UL13 fusion protein was absorbed to glutathione–
agarose beads (Sigma), washed with PBS-A, and eluted
with 10 mM reduced glutathione (Sigma) in 50 mM Tris–
HCl (pH 8.0). The eluted protein was quantified by a
protein assay (Bio-Rad). Two rabbits were injected twice
subcutaneously with 0.5 mg of the purified GST–UL13
fusion protein at Josman Laboratories (Napa, CA). After
the initial immunization, the rabbits were boosted at day
21 and serum was collected at day 28 and used in these
studies.
Preparation of radioactively labeled infected cell
lysate
To prepare 35S-labeled infected cell lysate, replicate
Vero cell cultures were exposed to 20 PFU of parent or
mutant viruses per cell. At 12.5 h after infection, the cells
were overlaid with 1 ml of medium deficient in methio-
nine and cysteine but supplemented with 50 mCi of
[35S]methionine and [35S]cysteine (sp act .1000 Ci/
mmol; Amersham, Arlington Heights, IL) for 6 h. The cells
were rinsed and then solubilized in 500 ml of RIPA buffer
[0.01 M Tris–HCl (pH 7.4), 0.15 M NaCl, 1% sodium de-
oxycholate, 1% Nonidet P-40, 0.1% SDS] containing
protease inhibitors [0.1 mM tosylsulfonylphenylalanyl-
chloromethyl ketone (TPCK), 0.1 mM tosyl-L-phenylala-
nine chloromethyl ketone, (TLCK), 0.1 mM phenylmeth-
ylsulfonyl fluoride (PMSF)] and subjected to
electrophoresis in denaturing polyacrylamide gels or to
immunoprecipitation.
To prepare 32P-labeled infected cell lysate, replicate
25-cm2 Vero cell cultures were exposed to 20 PFU of
parent or mutant viruses per cell. To label gE and gI, the
cells were preincubated in Eagle’s minimal essential
medium containing no phosphate and supplemented
with 1% dialyzed phosphate-free calf serum for 1 h at 13 h
after infection. Cells were labeled with 100 to 200 mCi of
32Pi (New England Nuclear) in 3 ml of medium for 4 h. To
label UL13 protein, infected cells were labeled from 6 to
22 h after infection. In both cases, cells were scraped
and washed in PBS-A and resuspended in 500 ml of RIPA
buffer containing protease inhibitors as described above.
Immunoprecipitation
Radiolabeled Vero cell lysate equivalent to half of a
25-cm2 culture flask was first precleared by exposure to
protein A-conjugated Sepharose beads (Sigma) at 4°C
for 1 h. The precleared lysate was reacted with a 1:100
dilution of preimmune, UL13, or UL32 polyclonal antisera
overnight at 4°C. The immune complex was then precip-
itated with protein A–Sepharose. After extensive wash-
ing of the Sepharose beads with PBS wash buffer (PBS-A
with 0.5% NP-40 and 0.1% SDS), immune complexes were
eluted from the beads by boiling for 5 min in disruption
TABLE 1





R7358 DUL13 repair DTK
R7032 DUS8 DgE
R7048 DUS7, DUS8 DgE, DgI, DTK
a (D) Gene containing deletion.
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buffer. The eluted proteins were electrophoretically sep-
arated in denaturing polyacrylamide gels. Anti-UL32 poly-
clonal antiserum was described previously (Chang et al.,
1996).
Electrophoretic separation and immunoblotting of
viral proteins
Replicate 25-cm2 flask cultures of rabbit skin cells or
Vero cells were exposed to 20 PFU parent or mutant
viruses per cell and maintained at 37°C for 24 h. UL13,
ICP22, and ICP27 in infected cells were detected by
immunoblotting as described previously (Ng et al., 1996).
Briefly, infected cells were pelleted by low-speed centrif-
ugation, rinsed in PBS-A, and resuspended in 200 ml of
disruption buffer [12.5 mM Tris–HCl (pH 6.8), 0.5% SDS,
2.5% glycerol, 5% b-mercaptoethanol]. Approximately
half of each sample was loaded onto each lane of a
denaturing 8.5% polyacrylamide gel. The electrophoreti-
cally separated polypeptides were electrically trans-
ferred to nitrocellulose membrane (Schleicher & Schuell)
and reacted with the appropriate antibodies. The bound
antibody was visualized with a second anti-mouse or
anti-rabbit IgG antibody conjugated to alkaline phos-
phatase (Bio-Rad). The rabbit polyclonal antibody R77
was directed against ICP22 (Ackermann et al., 1985).
Monoclonal antibody to ICP27 (H1117) was described by
Ackermann et al., (1984) and was purchased from Good-
win Institute (Plantation, FL).
To detect UL13 protein in the
35S-labeled cell lysate,
approximately 1⁄10 of a lysate of a 25-cm2 culture flask
was subjected to electrophoresis, electrically transferred
to nitrocellulose membrane, and reacted with the UL13
antiserum. The bound antibody was visualized with a
second anti-rabbit IgG antibody conjugated to horserad-
ish peroxidase and then to ECL detection reagents ac-
cording to the manufacturer’s instructions (Amersham).
To detect gE in the 35S- or 32P-labeled cell lysates, the
nitrocellulose was reacted with monoclonal antibody of
gE, II481B2, and the bound antibody was visualized with
a second anti-mouse antibody conjugated to alkaline
phosphatase. Monoclonal antibody II481B2 was a kind
gift of Patricia Spear (Para et al., 1985). Glycoprotein gI
was detected by immunoblotting with the monoclonal
antibody, Fd69 (Longnecker et al., 1987) and ECL detec-
tion reagents.
Protein kinase assay
UL13 was immunoprecipitated from unlabeled infected
Vero cell lysate as described above. To deplete the
HSV-1 Fc receptor before the immunoprecipitation with
UL13 antibody, the infected cell lysate was first reacted
with 10 ml of rabbit preimmune serum for 2 h and then
with protein A–Sepharose for 1.5 h. The Fc-depleted
lysate was then used for immunoprecipitation with the
UL13 antiserum as described above. The washed im-
mune complex on the protein A-conjugated Sepharose
beads was then washed once with protein kinase buffer
[50 mM Tris (pH 8), 50 mM MgCl2, 0.2 M NaCl, 0.1%
NP-40, 1 mM DTT]. The protein kinase buffer was mod-
ified from the buffer described by Cunningham et al.
(1992). Protein kinase assays were done as described
elsewhere (Ng et al., 1994). Briefly, the Sepharose beads
were incubated with 70 ml protein kinase buffer and 50
mCi of [g-32P]ATP (sp act 6000 Ci/mmol, DuPont/NEN) at
37°C for 30 min. The beads were then washed exten-
sively and the immune complexes were eluted from the
protein A beads by boiling for 5 min in disruption buffer.
Phosphorylation of gE by CKII
Phosphorylation of HSV gE by CKII in vitro was carried
out in a manner similar to the phosphorylation of VZV
ORF62 by CKII as described elsewhere (Ng et al., 1994).
Briefly, gE was immunoprecipitated from R7356 (DUL13)-
infected cells by the gE monoclonal antibody (H600)
(Longnecker and Roizman, 1986) or precipitated from
HSV-1(F)-infected cells by the UL13 antiserum as part of
the Fc receptor. The precipitate from the HSV-1(F)-in-
fected cells was heat-inactivated at 65°C for 10 min to
inactivate any protein kinase activity associated with the
precipitate. The protein kinase assay was initiated by
reacting the gE bound on protein A–Sepharose with 5
enzyme munits of CKII purified from sea star (Upstate
Biotechnology Inc.) in a CKII buffer [50 mM Tris (pH 7.5),
150 mM KCl, and 10 mM MgCl2] at 30°C for 30 min. To
test for the specificity of the activity of CKII, heparin in
concentrations of 0.5 or 5 mg/ml was added to individual
reaction mixtures before the protein kinase assay (Mitch-
ell et al., 1994). After five washes with PBS-A wash buffer,
gE was eluted from the protein A–Sepharose by boiling
in disruption buffer.
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